Integrated Radiology, Pathology, and Pharmacy Program to Accelerate Access to Osimertinib.
Ibiayi Dagogo-JackAmanda ManoogianNicholas JessopN Zeke GeorgantasFlorian J FintelmannAlexander FarahaniSubba R DigumarthyMelissa C PriceErik E FolchColleen M KeyesAndrew DoJennifer L PetersonMari A Mino-KenudsonMartha PitmanMiguel N RiveraValentina NardiDora Dias-SantagataLong P LeAnthony John IafrateRebecca S HeistLauren R RitterhouseJochen K LennerzPublished in: JCO oncology practice (2023)
A workflow involving radiology, pathology, pharmacy, and oncology reduced time between biopsy and osimertinib.